高级检索
当前位置: 首页 > 详情页

Traditional Chinese Medicine (TCM) in the treatment of COVID-19 and other viral infections: Efficacies and mechanisms

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

单位: [1]Department of Anesthesiology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, United States of America [2]Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China [3]Chinese Academy of Medical Sciences/Peking Union Medical College, Beijing, China
出处:
ISSN:

关键词: Traditional Chinese Medicine (TCM) Viral infections COVID-19 Jinhua Qinggan granules (JHQG) Lianhua Qingwen capsules (LHQW) Lung Cleansing and Detoxifying Decoction (LCDD) Xuanfeibaidu granules (XFBD) Huashibaidu granules (HSBD) Xuebijing (XBJ) Angiotensin converting enzyme 2 (ACE2) Coronavirus 3-chymotrypsin-like protease (3CL(pro)) Interleukin-6 (IL-6)

摘要:
COVID-19 has remained an uncontained, worldwide pandemic. While battling for the disease in China, six Traditional Chinese Medicine (TCM) recipes have been shown to be remarkably effective for treating patients with COVID-19. The present review discusses principles of TCM in curing infectious disease, and clinical evidence and mechanisms of the 6 most effective TCM recipes used in treating COVID-19 in 92% of all of the confirmed cases in China. Applications of TCM and specific recipes in the treatment of other viral infections, such as those caused by SARS-CoV, MERS-CoV, hepatitis B virus, hepatitis C virus, influenza A virus (including H1N1 and H7N9), influenza B, dengue virus as well as Ebola virus, are also discussed. Among the 6 TCM recipes, Jinhua Qinggan (JHQG) granules and Lianhua Qingwen (LHQW) capsules are recommended during medical observation; Lung Cleansing and Detoxifying Decoction (LCDD) is recommended for the treatment of both severe and non-severe patients; Xuanfeibaidu (XFBD) granules are recommended for treating moderate cases; while Huashibaidu (HSBD) and Xuebijing (XBJ) have been used in managing severe cases effectively. The common components and the active ingredients of the six TCM recipes have been summarized to reveal most promising drug candidates. The potential molecular mechanisms of the active ingredients in the six TCM recipes that target ACE2, 3CLpro and IL-6, revealed by molecular biological studies and/or network pharmacology prediction/molecular docking analysis/visualization analysis, are fully discussed. Therefore, further investigation of these TCM recipes may be of high translational value in enabling novel targeted therapies for COVID-19, potentially via purification and characterization of the active ingredients in the effective TCM recipes. (C) 2021 Elsevier Inc. All rights reserved.

语种:
被引次数:
WOS:
中科院(CAS)分区:
出版当年[2020]版
大类 | 1 区 医学
小类 | 1 区 药学
最新[2025]版
大类 | 1 区 医学
小类 | 1 区 药学
JCR分区:
出版当年[2019]版:
Q1 PHARMACOLOGY & PHARMACY
最新[2023]版:
Q1 PHARMACOLOGY & PHARMACY

影响因子: 最新[2023版] 最新五年平均[2021-2025] 出版当年[2019版] 出版当年五年平均[2015-2019] 出版前一年[2018版] 出版后一年[2020版]

第一作者:
第一作者单位: [1]Department of Anesthesiology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, United States of America
共同第一作者:
通讯作者:
通讯机构: [2]Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China [3]Chinese Academy of Medical Sciences/Peking Union Medical College, Beijing, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:1320 今日访问量:0 总访问量:816 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)